-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$45.38125.55% Upside
Arrowhead Pharmaceuticals, Inc. Frequently Asked Questions
-
What analysts cover Arrowhead Pharmaceuticals, Inc.?
Arrowhead Pharmaceuticals, Inc. has been rated by research analysts at Citigroup, H.C. Wainwright, Goldman Sachs, RBC Capital, Piper Sandler, Jefferies in the past 90 days.